Who We Are
VivaBioCell develops, manufactures and commercializes automated solutions for the manufacturing of advanced therapy medicinal products, for both research and clinical applications.
The company, born as a university spin-off, has evolved over years delivering several projects in the field of tissue engineering, medical devices and cell cultures automation, aimed at the development of new clinical applications.
In 2015 VivaBioCell was acquired by ImmunityBio Inc. (formerly NantCell Inc.), a subsidiary of NantWorks LLC group (Culver City, California), an ecosystem of companies focused on biotech, healthcare AI, and mobility.
This journey has brought into the company what we consider our main assets: the deep and diversified knowledge of our multidisciplinary team, together with strong and enduring partnerships with best-in-class clinical and technology stakeholders.
Mission & Vision
Our mission is to provide smart and cost-effective solutions that allow for the improvement and standardization of advanced therapies manufacturing.
Our systems together with the strong commitment in supporting the customers during all phases of set-up and validation, allow for a safe seamless conversion of a manual protocol into a high-standardized scalable process, drawing the attention on risk reduction and cost containment, while maintaining regulatory and quality requirements.
Indeed, we truly want to inspire the application and diffusion of sustainable advanced therapies, with the long-term vision of bridging regenerative medicine into the mainstream worldwide clinical practice.
Quality & Compliance
VivaBioCell has committed in implementing a certified Quality Management System, which helps us guarantee quality of our products and services.
In the effort of continuously improving all of our processes and to ensure the growth of our organization, we apply ISO 9001:2015 requirements to all steps of product development and service provision. We keep integrating relevant best practices to our activities, striving to care for and to meet the needs of our valuable partners, collaborators and customers.
Kiwa, a world top 20 leader in testing, inspection and certification, has certified VivaBioCell S.p.A. Quality Management System according to ISO 9001:2015 standard, acting as an independent third party.
At VivaBioCell we are keen to find partners from early clinical stages and establish with them cell-therapy manufacturing strategies for innovative product adoption into new markets.
Contact us to discuss about collaboration opportunities.